Pfizer Inc. (New York) Uplyso Alfataliglicerase Gaucher disease Received regulatory approval in Brazil 3/19/13 Prothena Corp

and Pfizer Inc

In 2007, dalbavancin, which was then owned by New York-based Pfizer Inc. (acquired in the Vicuron Pharmaceuticals Inc. buyout of 2005), got snagged in the FDA's shifting guidelines on antibiotic development, earning a rejection despite hitting its endpoint in an 800-patient noninferiority trial in skin infections

Pfizer Inc., of New York, said its palbociclib (PD-0332991), an oral and selective inhibitor of cyclin-dependent kinases 4 and 6, received breakthrough therapy designation by the FDA for the potential treatment of patients with breast cancer

Backed by $16 million from investors that include Pfizer Inc.'s venture arm, a new orphan drug accelerator called Cydan LLC aims to spin out as many as five new companies in the first four years

The first approved ADC, Mylotarg (gemtuzumab ozogamicin for injection, Pfizer Inc.), was pulled from the market due to toxicity issues, which in turn were due to an unstable linker

subsidiary, Asterias Biotherapeutics Inc., which is purchasing Geron's embryonic stem cell assets "We're getting to a tipping point where nanomedicine is going from an interesting technology to something that's being viewed as a here-and-now technology for the pharmaceutical industry." – Scott Minick, president and CEO of BIND Therapeutics Inc., discussing the company's second major 2013 partnership, with Pfizer Inc., to develop its Accurin technology "In order to solve the real health

is collaborating with Pfizer Inc

With the close of the financing, San Francisco-based Labrys acquired global rights to RN-307 a Phase II-ready anti-calcitonin gene-related peptide (CGRP) humanized monoclonal antibody (MAb) from Pfizer Inc

Results in the latter still fell short of those achieved by Pfizer Inc.'s approved 's Janus kinase inhibitor Xeljanz (tofacitinib citrate) in RA, causing AstraZeneca partner Rigel Pharmaceuticals Inc.'s stock (NASDAQ:RIGL) to tumble, closing Friday at $4.50, down $3.03, or 40.3 percent

An appellate court's ruling Wednesday against Pfizer Inc

Wednesday morning, the Cambridge, Mass.-based biotech revealed that Pfizer Inc

Tetragenetics Inc., of Cambridge, Mass., said it inked a deal with an option for an exclusive license with New York-based Pfizer Inc

10/9/12 10/30/12 $10 Periphagen bought Diamyd for $1 and 10% ownership, plus $10M in potential milestones Women's health business of Jazz Pharmaceuticals plc (Dublin, Ireland) Meda AB (Goteborg, Sweden) 10/17/12 10/17/12 $95 Meda purchased the business for $95M in cash NextWave Pharmaceuticals Inc. (Cupertino, Calif.) Pfizer Inc. (New York) 10/23/12 10/23/12 $680 Pfizer is buying NextWave for $255M, plus $425M in sales milestones OctoPlus NV (Leiden, the Netherlands) Dr. Reddy's Laboratories Ltd

renewed its research collaboration with Pfizer Inc

Pfizer Inc., of New York, said the European Commission granted conditional marketing authorization for Bosulif (bosutinib) for the treatment of adult patients with chronic phase, accelerated phase and blast phase Philadelphia chromosome-positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitors and for whom Gleevec (imatinib, Novartis AG), Tasigna (nilotinib, Novartis AG) and Sprycel (dasatinib, Bristol-Myers Squibb Co.) are not considered appropriate

KineMed Inc., of Emeryville, Calif., said it renewed a nonexclusive research collaboration with Pfizer Inc., of New York, to advance approaches for treating metabolic disease, in particular Type II diabetes

one famous example is rheumatoid arthritis drug Enbrel (etanercept, Amgen/Pfizer Inc.), which soaks up tumor necrosis factor

Setback in Treating Cognition in Schizophrenia Schizophrenia patients have a number of options in addition to Risperdal, including Zyprexa (olanzapine, Eli Lilly and Co.), Geodon (ziprasidone HCI, Pfizer Inc.), Clozaril (clozapine, Novartis AG), Fanapt (iloperidone, Vanda Pharmaceuticals Inc. and Novartis) and Abilify (aripiprazole, Bristol-Myers Squibb Co. and Otsuka Pharmaceutical Co. Ltd